EPO and kidney failure: Based on this information, Dr. Joseph Eschbach, a nephrologist with a large patient practice in Seattle, and John conceived the hypothesis that “kidney failure” represents the ideal disease model to test recombinant EPO as “hormone replacing therapy” [35].